Rafarma Pharmaceuticals Stock Analysis

Rafarma Pink Sheet Analysis Notes

The company recorded a loss per share of 0.01. Rafarma Pharmaceuticals had not issued any dividends in recent years. The entity had 1:10 split on the 20th of November 2012. Rafarma Pharmaceuticals, Inc., a multi-product pharmaceutical company, produces and sells drugs, generic antibiotics, and specialty pharmaceuticals in Russia. As of October 19, 2020, Rafarma Pharmaceuticals, Inc. operates as a subsidiary of R. D. RAFARMA PHARMACEUTICALS operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.The quote for Rafarma Pharmaceuticals is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Rafarma Pharmaceuticals contact the company at 801-210-7135 or learn more at https://rafarma.si.

Rafarma Pharmaceuticals Investment Alerts

Rafarma Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 110.29 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Rafarma Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Rafarma Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Rafarma Profitablity

The company has Profit Margin (PM) of (0.88) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.81) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.81.

Technical Drivers

As of the 24th of March, Rafarma Pharmaceuticals holds the Semi Deviation of 7.14, risk adjusted performance of 0.154, and Coefficient Of Variation of 612.68. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Rafarma Pharmaceuticals, as well as the relationship between them.

Rafarma Pharmaceuticals Price Movement Analysis

Rafarma Pharmaceuticals Outstanding Bonds

Rafarma Pharmaceuticals Predictive Daily Indicators

Rafarma Pharmaceuticals Forecast Models

Rafarma Pharmaceuticals' time-series forecasting models are one of many Rafarma Pharmaceuticals' pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Rafarma Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Rafarma Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Rafarma shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Rafarma Pharmaceuticals. By using and applying Rafarma Pink Sheet analysis, traders can create a robust methodology for identifying Rafarma entry and exit points for their positions.

When running Rafarma Pharmaceuticals' price analysis, check to measure Rafarma Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rafarma Pharmaceuticals is operating at the current time. Most of Rafarma Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Rafarma Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rafarma Pharmaceuticals' price. Additionally, you may evaluate how the addition of Rafarma Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.